Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
Abstract Background OnabotulinumtoxinA is approved for the prevention of headache in those with chronic migraine (CM); however, more clinical data on the risk-benefit profile for treatment beyond one year is desirable. Methods The Chronic Migraine OnabotulinuMtoxinA Prolonged Efficacy open Label (CO...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2018-02-01
|
| Serie: | The Journal of Headache and Pain |
| Soggetti: | |
| Accesso online: | http://link.springer.com/article/10.1186/s10194-018-0840-8 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|